ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

Bristol-myers Squibb Company Complete list of announcements declared & dividend announcements by Bristol-myers Squibb Company BMY

Bristol-myers Squibb Company BMY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Bristol-myers Squibb Company BMY

Bristol Myers Squibb Reports Positive Results From Phase 3 CheckMate-67T Trial
(RTTNews) - Halozyme Therapeutics, Inc. (HALO) Thursday said Bristol Myers Squibb (BMS) reported positive topline results from the Phase 3 CheckMate-67T trial evaluating subcutaneous Opdivo (nivolumab) with Halozyme's ENHANZE drug delivery technology for
Announcement as on 19 October 2023

Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to .8 billion
Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to .8 billion
Announcement as on 08 October 2023

: Bristol Myers Squibb set to double number of drugs in registrational trials
Bristol Myers Squibb Co. BMY said Thursday that it expects to double the number of drugs in registrational trials over the next 18 months. The pipeline updates, released ahead of the company’s research and development day Thursday, include a CD19-directe
Announcement as on 14 September 2023

: Bristol Myers Squibb stock extends bounce after announced billion accelerated buyback agreements
Shares of Bristol Myers Squibb Co. BMY got a 0.9% bump up in premarket trading Thursday, after the biopharmaceutical company announced billion in accelerated share repurchase agreements. The ASR represents 3.2% of the company’s market capitalization o
Announcement as on 10 August 2023

: Bristol Myers stock takes a hit from earnings miss and lower outlook amid disappointing Revlimid sales
Shares of Bristol Myers Squibb Co. BMY shed 2.2% in premarket trading Thursday, after the drugmaker missed second-quarter earnings expectations and cut its full-year outlook, amid a more rapid than expected decline in sales of its cancer treatment Revlimid
Announcement as on 27 July 2023

Announcements by Bristol-myers Squibb Company first page | Next page | Prev page |

BMY Bristol-myers Squibb Company current price & indicator signals

Moving Averages for Bristol-myers Squibb Company

  • 5Day Average: 63.47
  • 12Day Average: 64.7
  • 20Day Average: 65.67
  • 50Day Average: 64.1
  • 100Day Average: 60.47
  • 150Day Average: 60.17
  • 200Day Average: 58.96

BMY Indicators & signals

Indicator MACD (12,26,9)

64.3, 64.65, 0.19
Indicator MACD is in negative zone

Indicator ADX (14)

7.94, 20.28, 23.78
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BMY Bristol-myers Squibb Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
18 Fri Sep 2026 63.06 62.19 to 63.07 0.35% 4.87 times
17 Thu Sep 2026 62.84 62.52 to 64.35 -1.19% 1.61 times
16 Wed Sep 2026 63.60 63.22 to 64.39 -0.2% 1.25 times
15 Tue Sep 2026 63.73 63.15 to 64.13 -0.58% 1.32 times
14 Mon Sep 2026 64.10 63.83 to 65.29 0.72% 0.44 times
11 Fri Sep 2026 63.64 63.27 to 64.20 -0.17% 0.93 times
10 Thu Sep 2026 63.75 63.73 to 64.92 -1.02% 0.86 times
09 Wed Sep 2026 64.41 64.26 to 65.05 -0.43% 0.87 times
08 Tue Sep 2026 64.69 64.40 to 65.89 -3.19% 1.26 times
04 Fri Sep 2026 66.82 66.58 to 67.72 -1.87% 0.64 times
03 Thu Sep 2026 68.09 66.62 to 68.24 0.64% 0.82 times
02 Wed Sep 2026 67.66 66.64 to 67.73 1.11% 0.45 times

Videos related to: BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

BMY announcements Bristol-myers Squibb Company announcements and dividends declared USA

 

Back to top